by The Tutu Team | Sep 5, 2017 | Uncategorized
Source: OncLive Although drugs that target HER2 have transformed the prognosis for many patients with breast cancer, the development of resistant disease remains a significant clinical challenge. Dual blockade strategies have become a new standard of care for HER2-... 